Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed grouped question UIN question first answered answering member label previous answer version answering member constituency answering member printed answering member label
tabling member	label

Search

1234553

	registered interest
	date	15/09/2020
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Asthma: Medical Equipment
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care what estimate he has made of the size of the stockpiles of inhalers that are available for prescription or purchase in the UK as of 15 September 2020.
	tabling member constituency	Islington South and Finsbury
	tabling member printed	Emily Thornberry
	uin	90075
	answer	answer is ministerial correction date of answer 23/09/2020 answer text <p>Our priority is to ensure that patients continue to have access to medicines and medical products they need. We are working closely with industry, the National Health Service and others in the supply chain to ensure that precautions are in place to reduce the likelihood of future shortages</p><p>The Government continues to hold stockpiles of medicines, including many of those medicines raised in the Rt. hon. Member’s questions, to cope with a range of scenarios, and robust contingency planning continues to ensure that the country is prepared for a possible second peak of COVID-19 infections and the end of the Transition period.</p><p>The Essential Medicines Buffer Stock (EMBS) supports the NHS in the event of a pandemic or other health emergency by ensuring the continued availability of medicines that are in routine use within the NHS in the event that the supply chain is interrupted. Volumes of the medicines listed in the EBMS for the requested dates are shown in the following table. The original EMBS contracts ended in October 2019 and the current ones expire on 31 March 2021.</p><table><tbody><tr><td><p>Volumes in EMBS (packs/singles)</p></td><td><p>Prior to 31 October 2019</p></td><td><p>On 15 September 2020</p></td></tr><tr><td><p>paracetamol_500mg_Caps/Tabs 100 pack</p></td><td><p>706,072</p></td><td><p>2,965,503</p></td></tr><tr><td><p>paracetamol_500mg_Caps/Tabs 100 pack</p></td><td><p>4,942,506</p></td><td><p> </p></td></tr><tr><td><p>paracetamol_500mg-Caps/Tabs 100 pack</p></td><td><p>706,072</p></td><td><p> </p></td></tr><tr><td><p>paracetamol_125mg suppository 10 pack</p></td><td><p>3,578</p></td><td><p> </p></td></tr><tr><td><p>paracetamol_120mg/5ml liquid 100ml single</p></td><td><p>340,062</p></td><td><p> </p></td></tr><tr><td><p>paracetamol_250mg/5ml_liquid 100ml single</p></td><td><p>201,159</p></td><td><p> </p></td></tr><tr><td><p>paracetamol_500mg_Caps/Tabs 100 pack</p></td><td><p>706,072</p></td><td><p> </p></td></tr><tr><td><p>salbutamol_2mg/ml 2.5ml_nebules 20 pack</p></td><td><p>246,246</p></td><td><p> </p></td></tr><tr><td><p>Salbutamol_100mcg x 200 dose_MDI single inhalers</p></td><td><p>3,956,254</p></td><td><p>2,600,000</p></td></tr><tr><td><p>ibuprofen_100mg/5ml_liquid 100ml-150ml-500ml (volume in 100ml) singles</p></td><td><p>230,400</p></td><td><p> </p></td></tr><tr><td><p>ibuprofren_400mg_Caps/Tabs 84 pack</p></td><td><p>591,883</p></td><td><p> </p></td></tr><tr><td><p>amoxicillin_125mg/5ml_liquid 100ml singles</p></td><td><p>234,925</p></td><td><p> </p></td></tr><tr><td><p>amoxicillin_125mg/5ml_liquid 100ml singles</p></td><td><p>234,925</p></td><td><p> </p></td></tr><tr><td><p>amoxicillin_250mg_Caps/Tabs 21 pack</p></td><td><p>235,874</p></td><td><p> </p></td></tr><tr><td><p>amoxicillin_500mg_Caps/Tabs 21 pack</p></td><td><p>1,714,429</p></td><td><p> </p></td></tr><tr><td><p>amoxicillin_125mg/5ml_liquid 100ml singles</p></td><td><p>313,234</p></td><td><p> </p></td></tr><tr><td><p>Amoxicillin_250mg_Caps/Tabs 21 pack</p></td><td><p>157,249</p></td><td><p> </p></td></tr><tr><td><p>Amoxicillin_500mg_Caps/Tabs 21 pack</p></td><td><p>489,837</p></td><td><p> </p></td></tr></tbody></table><p> </p><p>In preparation for a potential imminent second wave of COVID-19 and to protect the security of the supply of critical life-saving medicines and patient health across the United Kingdom, a clinically-led assessment of medicines that should be stockpiled was undertaken in May and June 2020 and this was fed into a tender exercise that ran from 24 July to 10 August 2020.</p><p>Paracetamol and insulin are amongst the medicines that were identified and tendered for as part of this exercise and we will shortly be awarding contracts to secure supplies of these medicines for the autumn and winter. Details of the tender exercise can be found at the following links:</p><p><a href="https://ted.europa.eu/udl?uri=TED:NOTICE:355937-2020:HTML:EN:HTML&amp;tabId=1&amp;tabLang=en#id4-VI" target="_blank">https://ted.europa.eu/udl?uri=TED:NOTICE:355937-2020:HTML:EN:HTML&amp;tabId=1&amp;tabLang=en#id4-VI</a></p><p><a href="https://www.contractsfinder.service.gov.uk/Notice/b8bf439c-76d1-4fa6-952d-6b65bd659021" target="_blank">https://www.contractsfinder.service.gov.uk/Notice/b8bf439c-76d1-4fa6-952d-6b65bd659021</a></p><p>With regard to stocks of medicines on UK soil owned and held by suppliers themselves, commercially sensitive information has been shared confidentially with the Department by suppliers of medicines to the UK, to support various contingency programmes. For this reason, we cannot share information received from suppliers, including on their UK stock levels, with third parties.</p> answering member constituency Bury St Edmunds answering member printed Jo Churchill grouped question UIN 90068 90069 90070 90071 90072 90073 90074 90076 90077 90078 90079 90080 90081 90083 question first answered 23/09/2020 12:14:21 answering member 4380 label Biography information for Jo Churchill
	tabling member	1536 label Biography information for Emily Thornberry

1234555

	registered interest
	date	15/09/2020
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Asthma: Medical Equipment
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care when the Government last made an assessment of the level of stockpiling of inhalers required in preparation for (a) a second wave of covid-19 and (b) the end of the transition period and if he will publish that assessment.
	tabling member constituency	Islington South and Finsbury
	tabling member printed	Emily Thornberry
	uin	90076
	answer	answer is ministerial correction date of answer 23/09/2020 answer text <p>Our priority is to ensure that patients continue to have access to medicines and medical products they need. We are working closely with industry, the National Health Service and others in the supply chain to ensure that precautions are in place to reduce the likelihood of future shortages</p><p>The Government continues to hold stockpiles of medicines, including many of those medicines raised in the Rt. hon. Member’s questions, to cope with a range of scenarios, and robust contingency planning continues to ensure that the country is prepared for a possible second peak of COVID-19 infections and the end of the Transition period.</p><p>The Essential Medicines Buffer Stock (EMBS) supports the NHS in the event of a pandemic or other health emergency by ensuring the continued availability of medicines that are in routine use within the NHS in the event that the supply chain is interrupted. Volumes of the medicines listed in the EBMS for the requested dates are shown in the following table. The original EMBS contracts ended in October 2019 and the current ones expire on 31 March 2021.</p><table><tbody><tr><td><p>Volumes in EMBS (packs/singles)</p></td><td><p>Prior to 31 October 2019</p></td><td><p>On 15 September 2020</p></td></tr><tr><td><p>paracetamol_500mg_Caps/Tabs 100 pack</p></td><td><p>706,072</p></td><td><p>2,965,503</p></td></tr><tr><td><p>paracetamol_500mg_Caps/Tabs 100 pack</p></td><td><p>4,942,506</p></td><td><p> </p></td></tr><tr><td><p>paracetamol_500mg-Caps/Tabs 100 pack</p></td><td><p>706,072</p></td><td><p> </p></td></tr><tr><td><p>paracetamol_125mg suppository 10 pack</p></td><td><p>3,578</p></td><td><p> </p></td></tr><tr><td><p>paracetamol_120mg/5ml liquid 100ml single</p></td><td><p>340,062</p></td><td><p> </p></td></tr><tr><td><p>paracetamol_250mg/5ml_liquid 100ml single</p></td><td><p>201,159</p></td><td><p> </p></td></tr><tr><td><p>paracetamol_500mg_Caps/Tabs 100 pack</p></td><td><p>706,072</p></td><td><p> </p></td></tr><tr><td><p>salbutamol_2mg/ml 2.5ml_nebules 20 pack</p></td><td><p>246,246</p></td><td><p> </p></td></tr><tr><td><p>Salbutamol_100mcg x 200 dose_MDI single inhalers</p></td><td><p>3,956,254</p></td><td><p>2,600,000</p></td></tr><tr><td><p>ibuprofen_100mg/5ml_liquid 100ml-150ml-500ml (volume in 100ml) singles</p></td><td><p>230,400</p></td><td><p> </p></td></tr><tr><td><p>ibuprofren_400mg_Caps/Tabs 84 pack</p></td><td><p>591,883</p></td><td><p> </p></td></tr><tr><td><p>amoxicillin_125mg/5ml_liquid 100ml singles</p></td><td><p>234,925</p></td><td><p> </p></td></tr><tr><td><p>amoxicillin_125mg/5ml_liquid 100ml singles</p></td><td><p>234,925</p></td><td><p> </p></td></tr><tr><td><p>amoxicillin_250mg_Caps/Tabs 21 pack</p></td><td><p>235,874</p></td><td><p> </p></td></tr><tr><td><p>amoxicillin_500mg_Caps/Tabs 21 pack</p></td><td><p>1,714,429</p></td><td><p> </p></td></tr><tr><td><p>amoxicillin_125mg/5ml_liquid 100ml singles</p></td><td><p>313,234</p></td><td><p> </p></td></tr><tr><td><p>Amoxicillin_250mg_Caps/Tabs 21 pack</p></td><td><p>157,249</p></td><td><p> </p></td></tr><tr><td><p>Amoxicillin_500mg_Caps/Tabs 21 pack</p></td><td><p>489,837</p></td><td><p> </p></td></tr></tbody></table><p> </p><p>In preparation for a potential imminent second wave of COVID-19 and to protect the security of the supply of critical life-saving medicines and patient health across the United Kingdom, a clinically-led assessment of medicines that should be stockpiled was undertaken in May and June 2020 and this was fed into a tender exercise that ran from 24 July to 10 August 2020.</p><p>Paracetamol and insulin are amongst the medicines that were identified and tendered for as part of this exercise and we will shortly be awarding contracts to secure supplies of these medicines for the autumn and winter. Details of the tender exercise can be found at the following links:</p><p><a href="https://ted.europa.eu/udl?uri=TED:NOTICE:355937-2020:HTML:EN:HTML&amp;tabId=1&amp;tabLang=en#id4-VI" target="_blank">https://ted.europa.eu/udl?uri=TED:NOTICE:355937-2020:HTML:EN:HTML&amp;tabId=1&amp;tabLang=en#id4-VI</a></p><p><a href="https://www.contractsfinder.service.gov.uk/Notice/b8bf439c-76d1-4fa6-952d-6b65bd659021" target="_blank">https://www.contractsfinder.service.gov.uk/Notice/b8bf439c-76d1-4fa6-952d-6b65bd659021</a></p><p>With regard to stocks of medicines on UK soil owned and held by suppliers themselves, commercially sensitive information has been shared confidentially with the Department by suppliers of medicines to the UK, to support various contingency programmes. For this reason, we cannot share information received from suppliers, including on their UK stock levels, with third parties.</p> answering member constituency Bury St Edmunds answering member printed Jo Churchill grouped question UIN 90068 90069 90070 90071 90072 90073 90074 90075 90077 90078 90079 90080 90081 90083 question first answered 23/09/2020 12:14:21 answering member 4380 label Biography information for Jo Churchill
	tabling member	1536 label Biography information for Emily Thornberry

1229513

	registered interest
	date	28/08/2020
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Health Professions: Infectious Diseases
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, how many (a) consultants in communicable disease control and (b) community infection control nurses are working in those roles in each local authority area for the most recent period for which such information is available.
	tabling member constituency	Dulwich and West Norwood
	tabling member printed	Helen Hayes
	uin	82196
	answer	answer is ministerial correction date of answer 23/09/2020 answer text <p>The Department does not hold the information requested.</p> answering member constituency Bury St Edmunds answering member printed Jo Churchill question first answered 23/09/2020 11:20:01 answering member 4380 label Biography information for Jo Churchill
	tabling member	4510 label Biography information for Helen Hayes

1230583

	registered interest
	date	02/09/2020
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Influenza: Vaccination
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, how many flu vaccines (a) were administered to patients in 2019-20 and (b) he estimates will be required for winter 2020-21.
	tabling member constituency	Halton
	tabling member printed	Derek Twigg
	uin	84149
	answer	answer is ministerial correction date of answer 23/09/2020 answer text <p>In 2019/20, 15.3 million people received the flu vaccination. This included those aged 65 and older, those in at risk groups, pregnant women, children aged two – three years, children in reception – school year six and healthcare workers.</p><p>In 2020/21 we expect to offer more than 30 million vaccines.</p> answering member constituency Bury St Edmunds answering member printed Jo Churchill question first answered 23/09/2020 12:48:14 answering member 4380 label Biography information for Jo Churchill previous answer version 45043 answering member constituency Bury St Edmunds answering member printed Jo Churchill answering member 4380 label Biography information for Jo Churchill
	tabling member	429 label Biography information for Derek Twigg

1228802

	registered interest
	date	28/08/2020
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Influenza: Vaccination
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, how much his Department has budgeted for the 2020-21 flu vaccination campaign; how many doses have been ordered; and from (a) which companies and (b) where the vaccines will be produced.
	tabling member constituency	Warley
	tabling member printed	John Spellar
	uin	81513
	answer	answer is ministerial correction date of answer 23/09/2020 answer text <p>Public Health England’s media spend for the 2020 - 2021 influenza vaccination campaign budget is £4.15 million. The Department has agreed to procure 7.65 million additional doses of seasonal flu vaccine to date and continues to work with suppliers to increase the size of this additional stock. This is in addition to the stock that general practitioners and pharmacists have ordered directly from manufacturers for the adult programme.</p><p>The contracts for the additional vaccine are with Aventis Pharma Limited (T/A Sanofi), Mylan UK Healthcare Ltd, GlaxoSmithKline UK Ltd and Seqirus UK Ltd.</p><p>Production of the vaccine will include a number of processes. Some aspects include processing in the United Kingdom and some overseas.</p> answering member constituency Bury St Edmunds answering member printed Jo Churchill question first answered 23/09/2020 13:48:30 answering member 4380 label Biography information for Jo Churchill previous answer version 44268 answering member constituency Bury St Edmunds answering member printed Jo Churchill answering member 4380 label Biography information for Jo Churchill
	tabling member	318 label Biography information for John Spellar

1234061

	registered interest
	date	14/09/2020
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Medical Certificates: Fees and Charges
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, if he will make an estimate of the number of disabled people who are financially affected by charges for doctors letters and statements.
	tabling member constituency	Stockport
	tabling member printed	Navendu Mishra
	uin	89869
	answer	answer is ministerial correction date of answer 23/09/2020 answer text <p>The Department does not hold data on the number of disabled people who are financially affected by charges for doctors’ letters and statements.</p><p>The General Medical Services and Personal Medical Services Regulations contain a list of statutory certificates that general practitioner (GP) practices are required to provide without charge. Practices are free to charge for the completion of certificates, forms and letters that are not listed as being exempt. NHS England and NHS Improvement expect practices to charge a reasonable sum, appropriate for the workload involved.</p><p>The Government recognises that there are concerns about some fees GPs charge for letters to certify a patient’s health. We are now undertaking a thorough review of levels of bureaucracy in general practice to streamline processes, free up valuable time to care for patients and to ensure consistency and fairness of charges for certification.</p><p> </p> answering member constituency Bury St Edmunds answering member printed Jo Churchill question first answered 23/09/2020 10:45:02 answering member 4380 label Biography information for Jo Churchill
	tabling member	4811 label Biography information for Navendu Mishra

1228898

	registered interest
	date	28/08/2020
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Dental Services: Coronavirus
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, if he will provide clearer guidance to dentists on what services they are able to provide during the covid-19 outbreak; and whether dentists are permitted to make their own risk assessments on what services they can deliver.
	tabling member constituency	Tatton
	tabling member printed	Esther McVey
	uin	81861
	answer	answer is ministerial correction date of answer 23/09/2020 answer text <p>Dentists are already able to provide all treatments, including aerosol generating procedures, where they can do so safely. NHS England and NHS Improvement has issued a series of guidance notes setting out the personal protective equipment and infection control procedures required to deliver the full range of dentistry safely while COVID-19 is still circulating in the community. Routine National Health Service dental treatment was suspended during the pandemic peak and face to face urgent care was restricted to over 600 urgent dental centres to minimize risk of transmission. NHS England and NHS Improvement guidance at the end of May authorized a restart of NHS care including routine care from all practices from 8 June. Dentists have been encouraged to reopen as fast as possible as is compatible with safety.</p><p>Detailed guidance has been issued to dentists as they reopen for face to face care. The guidance can be found at the following link:</p><p><a href="https://www.england.nhs.uk/coronavirus/publication/preparedness-letters-for-dental-care/" target="_blank">https://www.england.nhs.uk/coronavirus/publication/preparedness-letters-for-dental-care/</a></p><p>All dentists, whether offering NHS or private care, are responsible for ensuring the care they offer is safe. Dentistry is regulated by the Care Quality Commission and the General Dental Council as well as, for NHS dentistry, NHS England and NHS Improvement.</p> answering member constituency Bury St Edmunds answering member printed Jo Churchill grouped question UIN 81860 question first answered 23/09/2020 13:17:32 answering member 4380 label Biography information for Jo Churchill previous answer version 44302 answering member constituency Bury St Edmunds answering member printed Jo Churchill answering member 4380 label Biography information for Jo Churchill
	tabling member	4084 label Biography information for Esther McVey

1228750

	registered interest
	date	28/08/2020
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Dental Services: Laboratories
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, if the Government will help support dental laboratories by paying them their average lab element fees.
	tabling member constituency	Shrewsbury and Atcham
	tabling member printed	Daniel Kawczynski
	uin	81724
	answer	answer is ministerial correction date of answer 23/09/2020 answer text <p>During the suspension of routine dentistry during the pandemic peak there was almost no demand for dental laboratory products. Demand continues to be significantly reduced post lock down as there is continued reduced activity in both National Health Service and private dentistry due to the need for heightened infection controls.</p><p>Dental laboratories do not receive funding from the NHS. Dentists, whether NHS or private, contract directly with laboratories as third party suppliers. It is therefore not possible for the NHS to direct NHS funding to laboratories for work not commissioned by dentists. However as private companies, laboratories were and are entitled to the full range of financial support from the Treasury available to private sector businesses and individuals affected financially by COVID-19.</p> answering member constituency Bury St Edmunds answering member printed Jo Churchill question first answered 23/09/2020 12:59:44 answering member 4380 label Biography information for Jo Churchill
	tabling member	1566 label Biography information for Daniel Kawczynski

1231221

	registered interest
	date	03/09/2020
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Sexually Transmitted Infections
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what additional steps his Department is taking to tackle sexually transmitted diseases.
	tabling member constituency	Hornsey and Wood Green
	tabling member printed	Catherine West
	uin	84719
	answer	answer is ministerial correction date of answer 23/09/2020 answer text <p>Local authorities in England are mandated to provide comprehensive open access sexual health services including access to the full range of contraception and sexually transmitted infection testing and treatment. The Government provides funding to local authorities for their public health responsibilities, including sexual health services, through the public health grant. It is for individual local authorities to decide their spending priorities based on an assessment of local need, including the need for sexual health services taking account of their statutory duties. The number of consultations at sexual health services increased by 7% between 2018 and 2019 (from 3,613,447 to 3,852,121).</p><p>Work on the development of a new national sexual and reproductive health strategy is underway with the Department working with Public Health England, NHS England and NHS Improvement, local government and other partners. Details of the strategy’s scope and objectives will be announced in due course.</p><p /><p /> answering member constituency Bury St Edmunds answering member printed Jo Churchill question first answered 23/09/2020 11:37:16 answering member 4380 label Biography information for Jo Churchill previous answer version 45721 answering member constituency Bury St Edmunds answering member printed Jo Churchill answering member 4380 label Biography information for Jo Churchill
	tabling member	4523 label Biography information for Catherine West

1229192

	registered interest
	date	28/08/2020
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Pharmacy: Disclosure of Information
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what assessment has he made of the efficacy of National Pharmacy Association advice to pharmacists responding to customer complaints that no admission of error should be made to customers; and whether that advice represents a contravention of Statutory Duty of Candour.
	tabling member constituency	Dulwich and West Norwood
	tabling member printed	Helen Hayes
	uin	82191
	answer	answer is ministerial correction date of answer 23/09/2020 answer text <p>Pharmacy regulators have set out in professional standards, that registered pharmacy professionals have a “duty of candour”, which includes an obligation to be open and honest when things go wrong and report and raise concerns. This is in line with other healthcare professionals.</p><p>The pharmacy regulator for Great Britain, the General Pharmaceutical Council’s (GPhC) inspection model, is designed to encourage the reporting and learning from errors. In fitness to practise hearings and sanctions guidance, the GPhC makes reference to the duty of candour, and that fitness to practice committees should take very seriously a finding that a pharmacy professional took deliberate steps to avoid being candid with a patient.</p><p> </p> answering member constituency Bury St Edmunds answering member printed Jo Churchill question first answered 23/09/2020 11:30:28 answering member 4380 label Biography information for Jo Churchill
	tabling member	4510 label Biography information for Helen Hayes